Fonte: Cancer Chemotherapy and Pharmacology. Unidade: FMRP
Assuntos: ANTINEOPLÁSICOS (TOXICIDADE), CITOCINAS (METABOLISMO), MUCOSA INTESTINAL (EFEITOS DE DROGAS), ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA JÚNIOR, Roberto César P. et al. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation. Cancer Chemotherapy and Pharmacology, v. 69, n. 4, p. 931-942, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00280-011-1780-z. Acesso em: 02 out. 2024.APA
Lima Júnior, R. C. P., Figueiredo, A. A., Freitas, H. C., Melo, M. L. P., Wong, D. V. T., Leite, C. A. V. G., et al. (2012). Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation. Cancer Chemotherapy and Pharmacology, 69( 4), 931-942. doi:10.1007/s00280-011-1780-zNLM
Lima Júnior RCP, Figueiredo AA, Freitas HC, Melo MLP, Wong DVT, Leite CAVG, Medeiros RP, Marques Neto RD, Vale ML, Brito GAC, Oriá RB, Souza MHLP, Cunha F de Q, Ribeiro RA. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation [Internet]. Cancer Chemotherapy and Pharmacology. 2012 ; 69( 4): 931-942.[citado 2024 out. 02 ] Available from: https://doi.org/10.1007/s00280-011-1780-zVancouver
Lima Júnior RCP, Figueiredo AA, Freitas HC, Melo MLP, Wong DVT, Leite CAVG, Medeiros RP, Marques Neto RD, Vale ML, Brito GAC, Oriá RB, Souza MHLP, Cunha F de Q, Ribeiro RA. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation [Internet]. Cancer Chemotherapy and Pharmacology. 2012 ; 69( 4): 931-942.[citado 2024 out. 02 ] Available from: https://doi.org/10.1007/s00280-011-1780-z
